DAVID POPLACK to Asparaginase
This is a "connection" page, showing publications DAVID POPLACK has written about Asparaginase.
Connection Strength
0.288
-
Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey. Cancer Chemother Pharmacol. 1993; 32(4):310-4.
Score: 0.099
-
Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Cancer Res. 1985 Jan; 45(1):217-20.
Score: 0.057
-
L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8.
Score: 0.046
-
Delayed allergic reactions following intramuscular L-asparaginase. Med Pediatr Oncol. 1980; 8(2):123-5.
Score: 0.040
-
Ascending myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: correlation with cerebrospinal fluid myelin basic protein. Med Pediatr Oncol. 1985; 13(1):4-8.
Score: 0.014
-
Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Cancer Treat Rep. 1981; 65 Suppl 4:93-6.
Score: 0.011
-
Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia. Cancer. 1980 Jun 15; 45(12):3090-4.
Score: 0.010
-
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood. 1998 Nov 15; 92(10):3569-77.
Score: 0.009